Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00220909Phase 4Terminated
Phase 4, randomised, double-blind trial of lansoprazole in stress ulcer and gastrointestinal bleeding (2 arms), sponsored by Temple University. Primary endpoint: Mucosal Erosions and Ulcerations at Day 4. Started Sep 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00220909.